

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | detection of molecule of bacterial origin (GO:0032490) | 7.99391567 |
| 2 | negative regulation of macroautophagy (GO:0016242) | 7.61151377 |
| 3 | auditory receptor cell stereocilium organization (GO:0060088) | 7.03582113 |
| 4 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 6.62774722 |
| 5 | post-embryonic morphogenesis (GO:0009886) | 6.26154286 |
| 6 | sulfate transmembrane transport (GO:1902358) | 5.56062581 |
| 7 | energy homeostasis (GO:0097009) | 5.55268222 |
| 8 | cellular anion homeostasis (GO:0030002) | 5.28969959 |
| 9 | detection of external biotic stimulus (GO:0098581) | 5.08560714 |
| 10 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 4.89357806 |
| 11 | inner ear receptor stereocilium organization (GO:0060122) | 4.75695037 |
| 12 | phosphate ion homeostasis (GO:0055062) | 4.69611187 |
| 13 | trivalent inorganic anion homeostasis (GO:0072506) | 4.69611187 |
| 14 | sulfate transport (GO:0008272) | 4.59698910 |
| 15 | mannose metabolic process (GO:0006013) | 4.55160684 |
| 16 | lateral ventricle development (GO:0021670) | 4.50522593 |
| 17 | negative regulation of meiosis (GO:0045835) | 4.40697179 |
| 18 | positive regulation of neurotransmitter secretion (GO:0001956) | 4.35558672 |
| 19 | detection of biotic stimulus (GO:0009595) | 4.35231135 |
| 20 | positive regulation of neurological system process (GO:0031646) | 4.19665004 |
| 21 | negative regulation of erythrocyte differentiation (GO:0045647) | 4.17258898 |
| 22 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 4.10332525 |
| 23 | response to pheromone (GO:0019236) | 3.98462972 |
| 24 | neuron remodeling (GO:0016322) | 3.96826131 |
| 25 | bicarbonate transport (GO:0015701) | 3.84125484 |
| 26 | negative regulation of response to nutrient levels (GO:0032108) | 3.70305395 |
| 27 | negative regulation of response to extracellular stimulus (GO:0032105) | 3.70305395 |
| 28 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress (GO:0043 | 3.65815515 |
| 29 | glycoside metabolic process (GO:0016137) | 3.59436575 |
| 30 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 3.55237881 |
| 31 | vocalization behavior (GO:0071625) | 3.42215004 |
| 32 | regulation of interleukin-6 biosynthetic process (GO:0045408) | 3.40795327 |
| 33 | positive regulation of neurotransmitter transport (GO:0051590) | 3.38258044 |
| 34 | positive regulation of vascular permeability (GO:0043117) | 3.38227020 |
| 35 | exogenous drug catabolic process (GO:0042738) | 3.33137030 |
| 36 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 3.32377285 |
| 37 | positive regulation of CREB transcription factor activity (GO:0032793) | 3.27866809 |
| 38 | semaphorin-plexin signaling pathway (GO:0071526) | 3.24152841 |
| 39 | positive regulation of histone deacetylation (GO:0031065) | 3.20306706 |
| 40 | regulation of extracellular matrix disassembly (GO:0010715) | 3.11756594 |
| 41 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 3.08923388 |
| 42 | regulation of ARF GTPase activity (GO:0032312) | 3.08844253 |
| 43 | prostate gland growth (GO:0060736) | 3.08052332 |
| 44 | sulfur compound transport (GO:0072348) | 3.07510682 |
| 45 | positive regulation of hormone biosynthetic process (GO:0046886) | 3.03610634 |
| 46 | daunorubicin metabolic process (GO:0044597) | 20.8591414 |
| 47 | polyketide metabolic process (GO:0030638) | 20.8591414 |
| 48 | doxorubicin metabolic process (GO:0044598) | 20.8591414 |
| 49 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.97061379 |
| 50 | estrogen biosynthetic process (GO:0006703) | 2.94284742 |
| 51 | regulation of glutamate receptor signaling pathway (GO:1900449) | 2.93863504 |
| 52 | negative regulation of granulocyte differentiation (GO:0030853) | 2.93267195 |
| 53 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.92232992 |
| 54 | positive regulation of uterine smooth muscle contraction (GO:0070474) | 2.91423752 |
| 55 | inositol metabolic process (GO:0006020) | 2.89742625 |
| 56 | positive regulation of protein sumoylation (GO:0033235) | 2.89187238 |
| 57 | peptidyl-lysine dimethylation (GO:0018027) | 2.89028846 |
| 58 | histone H3-K9 modification (GO:0061647) | 2.84442120 |
| 59 | maintenance of gastrointestinal epithelium (GO:0030277) | 2.83972279 |
| 60 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.81957607 |
| 61 | negative regulation of phosphatidylinositol 3-kinase signaling (GO:0014067) | 2.81400668 |
| 62 | thymic T cell selection (GO:0045061) | 2.80592673 |
| 63 | positive thymic T cell selection (GO:0045059) | 2.79498115 |
| 64 | negative regulation of glial cell proliferation (GO:0060253) | 2.75729360 |
| 65 | tachykinin receptor signaling pathway (GO:0007217) | 2.70947010 |
| 66 | drinking behavior (GO:0042756) | 2.70645857 |
| 67 | positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:00360 | 2.67310985 |
| 68 | regulation of ARF protein signal transduction (GO:0032012) | 2.66625853 |
| 69 | endothelial cell chemotaxis (GO:0035767) | 2.66579638 |
| 70 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 2.64654070 |
| 71 | macrophage activation (GO:0042116) | 2.64049844 |
| 72 | regulation of activation of Janus kinase activity (GO:0010533) | 2.63951777 |
| 73 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 2.62353823 |
| 74 | negative regulation of meiotic cell cycle (GO:0051447) | 2.61546828 |
| 75 | cell proliferation involved in metanephros development (GO:0072203) | 2.61235529 |
| 76 | opioid receptor signaling pathway (GO:0038003) | 2.59607619 |
| 77 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.59281299 |
| 78 | cell-cell junction maintenance (GO:0045217) | 2.57806505 |
| 79 | activation of JUN kinase activity (GO:0007257) | 2.53234377 |
| 80 | negative regulation of cell killing (GO:0031342) | 2.52844372 |
| 81 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.52844372 |
| 82 | positive regulation of protein deacetylation (GO:0090312) | 2.52552755 |
| 83 | positive regulation of blood vessel endothelial cell migration (GO:0043536) | 2.51625507 |
| 84 | response to muramyl dipeptide (GO:0032495) | 2.51335708 |
| 85 | long term synaptic depression (GO:0060292) | 2.51199427 |
| 86 | positive regulation of protein kinase C signaling (GO:0090037) | 2.50897848 |
| 87 | atrioventricular valve morphogenesis (GO:0003181) | 2.49133453 |
| 88 | negative regulation of cell size (GO:0045792) | 2.48318522 |
| 89 | positive regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030949) | 2.48033867 |
| 90 | G-protein coupled receptor internalization (GO:0002031) | 2.46884066 |
| 91 | cellular response to vascular endothelial growth factor stimulus (GO:0035924) | 2.46381631 |
| 92 | glycine transport (GO:0015816) | 2.45394468 |
| 93 | adherens junction assembly (GO:0034333) | 2.43494546 |
| 94 | vascular endothelial growth factor signaling pathway (GO:0038084) | 2.43365215 |
| 95 | pigment granule localization (GO:0051875) | 2.42207291 |
| 96 | cell-substrate junction assembly (GO:0007044) | 2.41496950 |
| 97 | forebrain neuron differentiation (GO:0021879) | 2.40007722 |
| 98 | insulin-like growth factor receptor signaling pathway (GO:0048009) | 2.39552167 |
| 99 | venous blood vessel morphogenesis (GO:0048845) | 2.39142428 |
| 100 | protein heterotrimerization (GO:0070208) | 2.38441997 |
| 101 | drug catabolic process (GO:0042737) | 2.37030380 |
| 102 | response to laminar fluid shear stress (GO:0034616) | 2.36978238 |
| 103 | cell-substrate adherens junction assembly (GO:0007045) | 2.36848494 |
| 104 | focal adhesion assembly (GO:0048041) | 2.36848494 |
| 105 | germinal center formation (GO:0002467) | 2.36744342 |
| 106 | cell migration involved in heart development (GO:0060973) | 2.35692417 |
| 107 | regulation of uterine smooth muscle contraction (GO:0070472) | 2.35091505 |
| 108 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.34971563 |
| 109 | negative regulation of calcium ion transport into cytosol (GO:0010523) | 2.34830635 |
| 110 | protein localization to endosome (GO:0036010) | 2.33256024 |
| 111 | negative regulation of autophagy (GO:0010507) | 2.32054144 |
| 112 | virion attachment to host cell (GO:0019062) | 2.31748770 |
| 113 | adhesion of symbiont to host cell (GO:0044650) | 2.31748770 |
| 114 | positive regulation of receptor recycling (GO:0001921) | 2.31197552 |
| 115 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.30480883 |
| 116 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 2.30237666 |
| 117 | stress fiber assembly (GO:0043149) | 2.29941294 |
| 118 | positive regulation of glycolytic process (GO:0045821) | 2.29867356 |
| 119 | negative regulation of fatty acid transport (GO:2000192) | 2.29793794 |
| 120 | somatic stem cell division (GO:0048103) | 2.28569047 |
| 121 | adhesion of symbiont to host (GO:0044406) | 2.26987314 |
| 122 | dendritic spine organization (GO:0097061) | 2.25731263 |
| 123 | positive regulation of protein dephosphorylation (GO:0035307) | 2.25002625 |
| 124 | desmosome organization (GO:0002934) | 2.24982198 |
| 125 | cerebral cortex radially oriented cell migration (GO:0021799) | 2.24192611 |
| 126 | hemidesmosome assembly (GO:0031581) | 2.23081053 |
| 127 | detection of chemical stimulus (GO:0009593) | 2.22799970 |
| 128 | vascular endothelial growth factor receptor signaling pathway (GO:0048010) | 2.22469695 |
| 129 | head development (GO:0060322) | 2.22202753 |
| 130 | retrograde transport, endosome to Golgi (GO:0042147) | 2.21792970 |
| 131 | locomotory exploration behavior (GO:0035641) | 2.21663973 |
| 132 | response to fluid shear stress (GO:0034405) | 2.21433902 |
| 133 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.20574342 |
| 134 | pigment granule transport (GO:0051904) | 2.20158639 |
| 135 | neuronal ion channel clustering (GO:0045161) | 2.19887020 |
| 136 | cell volume homeostasis (GO:0006884) | 2.19755991 |
| 137 | positive T cell selection (GO:0043368) | 2.19709825 |
| 138 | positive regulation of phosphoprotein phosphatase activity (GO:0032516) | 2.19230393 |
| 139 | apoptotic process involved in morphogenesis (GO:0060561) | 2.17920736 |
| 140 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.17370103 |
| 141 | T cell selection (GO:0045058) | 2.16408635 |
| 142 | signal complex assembly (GO:0007172) | 2.16224247 |
| 143 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.15610821 |
| 144 | regulation of pigment cell differentiation (GO:0050932) | 2.15204286 |
| 145 | eye photoreceptor cell development (GO:0042462) | 2.15093617 |
| 146 | epithelial structure maintenance (GO:0010669) | 2.14776400 |
| 147 | regulation of gamma-delta T cell activation (GO:0046643) | 2.14486728 |
| 148 | regulation of synaptic vesicle exocytosis (GO:2000300) | 2.13776040 |
| 149 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.13695134 |
| 150 | azole transport (GO:0045117) | 2.12678350 |
| 151 | planar cell polarity pathway involved in neural tube closure (GO:0090179) | 2.12186707 |
| 152 | basement membrane organization (GO:0071711) | 2.11996471 |
| 153 | mesonephros development (GO:0001823) | 2.11544052 |
| 154 | cell proliferation involved in kidney development (GO:0072111) | 2.10789888 |
| 155 | regulation of extracellular matrix organization (GO:1903053) | 2.10250819 |
| 156 | NIK/NF-kappaB signaling (GO:0038061) | 2.09713308 |
| 157 | neurological system process involved in regulation of systemic arterial blood pressure (GO:0001976) | 2.09650918 |
| 158 | cell junction maintenance (GO:0034331) | 2.09606920 |
| 159 | sialylation (GO:0097503) | 2.09537724 |
| 160 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition | 2.09501721 |
| 161 | regulation of receptor internalization (GO:0002090) | 2.09415123 |
| 162 | tolerance induction (GO:0002507) | 2.08857193 |
| 163 | mRNA transcription from RNA polymerase II promoter (GO:0042789) | 2.08814023 |
| 164 | positive regulation of hormone metabolic process (GO:0032352) | 2.08236789 |
| 165 | establishment of pigment granule localization (GO:0051905) | 2.08206278 |
| 166 | barbed-end actin filament capping (GO:0051016) | 2.08070001 |
| 167 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.08014990 |
| 168 | activation of MAPKKK activity (GO:0000185) | 2.06300974 |
| 169 | regulation of fatty acid beta-oxidation (GO:0031998) | 2.04803890 |
| 170 | histone H4 deacetylation (GO:0070933) | 2.04703078 |
| 171 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.04517273 |
| 172 | chondroitin sulfate catabolic process (GO:0030207) | 2.04092648 |
| 173 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 2.03859658 |
| 174 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.03352533 |
| 175 | regulation of cell migration involved in sprouting angiogenesis (GO:0090049) | 2.01165651 |
| 176 | positive regulation of extracellular matrix organization (GO:1903055) | 2.01103312 |
| 177 | regulation of histone deacetylation (GO:0031063) | 2.00991264 |
| 178 | regulation of NFAT protein import into nucleus (GO:0051532) | 2.00193182 |
| 179 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.00177299 |
| 180 | aminoglycoside antibiotic metabolic process (GO:0030647) | 13.5959530 |
| 181 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 1.98201178 |
| 182 | endocytic recycling (GO:0032456) | 1.97948629 |
| 183 | positive regulation of Rap GTPase activity (GO:0032854) | 1.96860791 |
| 184 | negative thymic T cell selection (GO:0045060) | 1.96719549 |
| 185 | detection of bacterium (GO:0016045) | 1.95515159 |
| 186 | negative regulation of type 2 immune response (GO:0002829) | 1.93268775 |
| 187 | regulation of early endosome to late endosome transport (GO:2000641) | 1.93226259 |
| 188 | negative regulation of Ras protein signal transduction (GO:0046580) | 1.91039961 |
| 189 | negative regulation of myotube differentiation (GO:0010832) | 1.90732864 |
| 190 | regulation of necroptotic process (GO:0060544) | 1.88309867 |
| 191 | histone H3 deacetylation (GO:0070932) | 1.87811958 |
| 192 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 1.87733019 |
| 193 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 1.87512413 |
| 194 | dermatan sulfate metabolic process (GO:0030205) | 1.86981416 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.59576014 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.47378426 |
| 3 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 3.31625974 |
| 4 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.97240344 |
| 5 | * LXR_22292898_ChIP-Seq_THP-1_Human | 2.91281943 |
| 6 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.75713733 |
| 7 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.70600999 |
| 8 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.70503946 |
| 9 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.62942101 |
| 10 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.54488163 |
| 11 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.54488163 |
| 12 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.51892565 |
| 13 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.49377387 |
| 14 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.48607666 |
| 15 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.43635996 |
| 16 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.42079955 |
| 17 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.39539404 |
| 18 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.35250960 |
| 19 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.33185407 |
| 20 | KDM2B_26808549_Chip-Seq_DND41_Human | 2.26054446 |
| 21 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.24938455 |
| 22 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.23387609 |
| 23 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 2.21301188 |
| 24 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.20324540 |
| 25 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.09901013 |
| 26 | RACK7_27058665_Chip-Seq_MCF-7_Human | 2.06258943 |
| 27 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.05982453 |
| 28 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.03988636 |
| 29 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.02846815 |
| 30 | KDM2B_26808549_Chip-Seq_K562_Human | 1.98456130 |
| 31 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.96023363 |
| 32 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.94970307 |
| 33 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.93721489 |
| 34 | RXR_22108803_ChIP-Seq_LS180_Human | 1.89833759 |
| 35 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.86392643 |
| 36 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.85292825 |
| 37 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.84427256 |
| 38 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.84227441 |
| 39 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.81711201 |
| 40 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.77666020 |
| 41 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.77517299 |
| 42 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.76571894 |
| 43 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.74673291 |
| 44 | MYC_22102868_ChIP-Seq_BL_Human | 1.74391615 |
| 45 | * P68_20966046_ChIP-Seq_HELA_Human | 1.72604165 |
| 46 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.71968497 |
| 47 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.71388652 |
| 48 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.65221980 |
| 49 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.64009793 |
| 50 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.63703125 |
| 51 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.63194275 |
| 52 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.62678857 |
| 53 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.60133244 |
| 54 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.59124466 |
| 55 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.55343860 |
| 56 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.53781142 |
| 57 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.53705473 |
| 58 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.53060765 |
| 59 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.51844148 |
| 60 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.51817166 |
| 61 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.50635585 |
| 62 | * CTCF_27219007_Chip-Seq_Bcells_Human | 1.50425024 |
| 63 | P300_19829295_ChIP-Seq_ESCs_Human | 1.49833767 |
| 64 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.48949722 |
| 65 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.48476743 |
| 66 | * SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.47418337 |
| 67 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.47095887 |
| 68 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.46293595 |
| 69 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.46055422 |
| 70 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.44338720 |
| 71 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.41160825 |
| 72 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.40209578 |
| 73 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.40182655 |
| 74 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.39415356 |
| 75 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.35645465 |
| 76 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.35272960 |
| 77 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.35161721 |
| 78 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.34819021 |
| 79 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.33931378 |
| 80 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.33736866 |
| 81 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.33570449 |
| 82 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.32612738 |
| 83 | * TP63_22573176_ChIP-Seq_HFKS_Human | 1.32019697 |
| 84 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.31545928 |
| 85 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.31370911 |
| 86 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.30319441 |
| 87 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.29179627 |
| 88 | MAF_26560356_Chip-Seq_TH1_Human | 1.28939707 |
| 89 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.28056630 |
| 90 | MAF_26560356_Chip-Seq_TH2_Human | 1.27869143 |
| 91 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.26987466 |
| 92 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.26938362 |
| 93 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.26845365 |
| 94 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.26605446 |
| 95 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.26567488 |
| 96 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.25687222 |
| 97 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.25270640 |
| 98 | VDR_22108803_ChIP-Seq_LS180_Human | 1.24546002 |
| 99 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.23968785 |
| 100 | AR_25329375_ChIP-Seq_VCAP_Human | 1.23959939 |
| 101 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.23393195 |
| 102 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.22862202 |
| 103 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.21457354 |
| 104 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.21356306 |
| 105 | UTX_26944678_Chip-Seq_JUKART_Human | 1.20787264 |
| 106 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.20491807 |
| 107 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.20407235 |
| 108 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.20338727 |
| 109 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.18673731 |
| 110 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.18148032 |
| 111 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.16638884 |
| 112 | * ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.16021935 |
| 113 | * SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.15534189 |
| 114 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.15392153 |
| 115 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.14822244 |
| 116 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.14712563 |
| 117 | GATA1_19941826_ChIP-Seq_K562_Human | 1.14345014 |
| 118 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.13419574 |
| 119 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.12826241 |
| 120 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.12629660 |
| 121 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.12496657 |
| 122 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.11638681 |
| 123 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.10858218 |
| 124 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.10350417 |
| 125 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.08654794 |
| 126 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.08654794 |
| 127 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.08387085 |
| 128 | SA1_27219007_Chip-Seq_Bcells_Human | 1.08143613 |
| 129 | SPI1_23127762_ChIP-Seq_K562_Human | 1.07952179 |
| 130 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 1.07744553 |
| 131 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.07048080 |
| 132 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.06882881 |
| 133 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.06775398 |
| 134 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.06598813 |
| 135 | TCF4_23295773_ChIP-Seq_U87_Human | 1.06588774 |
| 136 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.06411887 |
| 137 | STAT3_23295773_ChIP-Seq_U87_Human | 1.06182185 |
| 138 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.06160930 |
| 139 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.05925729 |
| 140 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.05907964 |
| 141 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.05903063 |
| 142 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.05641086 |
| 143 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 1.05315152 |
| 144 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.05304507 |
| 145 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.05135490 |
| 146 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.04705506 |
| 147 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 1.04253712 |
| 148 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.03633418 |
| 149 | CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 1.03314201 |
| 150 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.02891903 |
| 151 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.02209012 |
| 152 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.01915178 |
| 153 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 1.01828739 |
| 154 | * MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.01602454 |
| 155 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.01513362 |
| 156 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 1.01495775 |
| 157 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 1.01492622 |
| 158 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.01102008 |
| 159 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.99875516 |
| 160 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.99441221 |
| 161 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 0.99348187 |
| 162 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 0.99166763 |
| 163 | * NCOR1_26117541_ChIP-Seq_K562_Human | 0.99157307 |
| 164 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 0.99156506 |
| 165 | PHF8_20622854_ChIP-Seq_HELA_Human | 0.98701110 |
| 166 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.98504359 |
| 167 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 0.97997696 |
| 168 | P53_22387025_ChIP-Seq_ESCs_Mouse | 0.97814541 |
| 169 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.97738487 |
| 170 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.97433972 |
| 171 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.96945422 |
| 172 | TP53_23651856_ChIP-Seq_MEFs_Mouse | 0.96713885 |
| 173 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.96682116 |
| 174 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.95410049 |
| 175 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.95410049 |
| 176 | TBL1_22424771_ChIP-Seq_293T_Human | 0.95054251 |
| 177 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 0.94748086 |
| 178 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.93993526 |
| 179 | AR_21572438_ChIP-Seq_LNCaP_Human | 0.93814008 |
| 180 | * RARB_27405468_Chip-Seq_BRAIN_Mouse | 0.92652992 |
| 181 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.92465071 |
| 182 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.92018006 |
| 183 | TP53_16413492_ChIP-PET_HCT116_Human | 0.91852358 |
| 184 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.91393839 |
| 185 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 0.90948789 |
| 186 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 0.90819090 |
| 187 | AR_19668381_ChIP-Seq_PC3_Human | 0.90793406 |
| 188 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.90656263 |
| 189 | TCF4_22108803_ChIP-Seq_LS180_Human | 0.90269968 |
| 190 | KDM2B_26808549_Chip-Seq_REH_Human | 0.88795749 |
| 191 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.88184505 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003878_abnormal_ear_physiology | 7.60138445 |
| 2 | MP0005377_hearing/vestibular/ear_phenot | 7.60138445 |
| 3 | MP0008004_abnormal_stomach_pH | 6.67490631 |
| 4 | MP0003879_abnormal_hair_cell | 4.06541522 |
| 5 | MP0005645_abnormal_hypothalamus_physiol | 3.83497269 |
| 6 | MP0003705_abnormal_hypodermis_morpholog | 3.81246689 |
| 7 | MP0000678_abnormal_parathyroid_gland | 3.29339938 |
| 8 | MP0008438_abnormal_cutaneous_collagen | 3.19688902 |
| 9 | MP0003279_aneurysm | 3.06642722 |
| 10 | MP0003172_abnormal_lysosome_physiology | 3.05448360 |
| 11 | MP0005423_abnormal_somatic_nervous | 2.85531283 |
| 12 | MP0005058_abnormal_lysosome_morphology | 2.85289237 |
| 13 | MP0003646_muscle_fatigue | 2.80560520 |
| 14 | MP0001958_emphysema | 2.75582872 |
| 15 | MP0001485_abnormal_pinna_reflex | 2.73868957 |
| 16 | MP0009697_abnormal_copulation | 2.68662234 |
| 17 | MP0006292_abnormal_olfactory_placode | 2.55580505 |
| 18 | MP0004742_abnormal_vestibular_system | 2.54302233 |
| 19 | MP0000566_synostosis | 2.44370809 |
| 20 | MP0003436_decreased_susceptibility_to | 2.43717493 |
| 21 | MP0004859_abnormal_synaptic_plasticity | 2.33649668 |
| 22 | MP0005409_darkened_coat_color | 2.18808468 |
| 23 | MP0001486_abnormal_startle_reflex | 2.15334159 |
| 24 | MP0009840_abnormal_foam_cell | 2.14000724 |
| 25 | MP0003303_peritoneal_inflammation | 2.10432681 |
| 26 | MP0003880_abnormal_central_pattern | 2.06210241 |
| 27 | MP0000751_myopathy | 1.95586901 |
| 28 | MP0006276_abnormal_autonomic_nervous | 1.94472982 |
| 29 | MP0001986_abnormal_taste_sensitivity | 1.91559248 |
| 30 | MP0001849_ear_inflammation | 1.89702426 |
| 31 | MP0002933_joint_inflammation | 1.89478333 |
| 32 | MP0005275_abnormal_skin_tensile | 1.88827683 |
| 33 | MP0009384_cardiac_valve_regurgitation | 1.85238540 |
| 34 | MP0003941_abnormal_skin_development | 1.84051281 |
| 35 | MP0003300_gastrointestinal_ulcer | 1.83150313 |
| 36 | MP0001348_abnormal_lacrimal_gland | 1.77659652 |
| 37 | MP0004947_skin_inflammation | 1.76632616 |
| 38 | MP0002735_abnormal_chemical_nociception | 1.66788342 |
| 39 | MP0003091_abnormal_cell_migration | 1.60083412 |
| 40 | MP0009046_muscle_twitch | 1.58755005 |
| 41 | MP0002277_abnormal_respiratory_mucosa | 1.58066701 |
| 42 | MP0005670_abnormal_white_adipose | 1.56414588 |
| 43 | MP0005646_abnormal_pituitary_gland | 1.55905837 |
| 44 | MP0000003_abnormal_adipose_tissue | 1.55044761 |
| 45 | MP0001873_stomach_inflammation | 1.53984459 |
| 46 | MP0005375_adipose_tissue_phenotype | 1.51552787 |
| 47 | MP0004130_abnormal_muscle_cell | 1.50296171 |
| 48 | MP0000767_abnormal_smooth_muscle | 1.47963817 |
| 49 | MP0003329_amyloid_beta_deposits | 1.44592269 |
| 50 | MP0005666_abnormal_adipose_tissue | 1.42843992 |
| 51 | MP0000685_abnormal_immune_system | 1.42362921 |
| 52 | MP0003045_fibrosis | 1.42150036 |
| 53 | MP0009278_abnormal_bone_marrow | 1.42033445 |
| 54 | MP0000013_abnormal_adipose_tissue | 1.41144015 |
| 55 | MP0001440_abnormal_grooming_behavior | 1.40716150 |
| 56 | MP0001533_abnormal_skeleton_physiology | 1.39762336 |
| 57 | MP0002572_abnormal_emotion/affect_behav | 1.38592334 |
| 58 | MP0005451_abnormal_body_composition | 1.37958894 |
| 59 | MP0009745_abnormal_behavioral_response | 1.37643062 |
| 60 | MP0008260_abnormal_autophagy | 1.37297784 |
| 61 | MP0002557_abnormal_social/conspecific_i | 1.35026963 |
| 62 | MP0001968_abnormal_touch/_nociception | 1.34612342 |
| 63 | MP0001501_abnormal_sleep_pattern | 1.32242612 |
| 64 | MP0004381_abnormal_hair_follicle | 1.31806164 |
| 65 | MP0003453_abnormal_keratinocyte_physiol | 1.29345610 |
| 66 | MP0005023_abnormal_wound_healing | 1.28019997 |
| 67 | MP0003635_abnormal_synaptic_transmissio | 1.22514970 |
| 68 | MP0004858_abnormal_nervous_system | 1.20182691 |
| 69 | MP0002272_abnormal_nervous_system | 1.18404346 |
| 70 | MP0003724_increased_susceptibility_to | 1.18261952 |
| 71 | MP0003191_abnormal_cellular_cholesterol | 1.17968167 |
| 72 | MP0002132_abnormal_respiratory_system | 1.17943976 |
| 73 | MP0005360_urolithiasis | 1.14934290 |
| 74 | MP0001664_abnormal_digestion | 1.14262857 |
| 75 | MP0000604_amyloidosis | 1.13752353 |
| 76 | MP0002419_abnormal_innate_immunity | 1.12728983 |
| 77 | MP0003763_abnormal_thymus_physiology | 1.12369847 |
| 78 | MP0002184_abnormal_innervation | 1.11866847 |
| 79 | MP0010155_abnormal_intestine_physiology | 1.10197384 |
| 80 | MP0002060_abnormal_skin_morphology | 1.09740760 |
| 81 | MP0005076_abnormal_cell_differentiation | 1.09623234 |
| 82 | MP0002938_white_spotting | 1.09572598 |
| 83 | MP0005390_skeleton_phenotype | 1.07633214 |
| 84 | MP0002064_seizures | 1.07427297 |
| 85 | MP0005025_abnormal_response_to | 1.07130023 |
| 86 | MP0004924_abnormal_behavior | 0.99503917 |
| 87 | MP0005386_behavior/neurological_phenoty | 0.99503917 |
| 88 | MP0005000_abnormal_immune_tolerance | 0.99427550 |
| 89 | MP0001800_abnormal_humoral_immune | 0.94773450 |
| 90 | MP0008874_decreased_physiological_sensi | 0.94409242 |
| 91 | MP0002971_abnormal_brown_adipose | 0.94240477 |
| 92 | MP0000681_abnormal_thyroid_gland | 0.94163538 |
| 93 | MP0003690_abnormal_glial_cell | 0.93237014 |
| 94 | MP0004185_abnormal_adipocyte_glucose | 0.93131317 |
| 95 | MP0002249_abnormal_larynx_morphology | 0.92886055 |
| 96 | MP0003183_abnormal_peptide_metabolism | 0.91583679 |
| 97 | MP0006082_CNS_inflammation | 0.90826017 |
| 98 | MP0000733_abnormal_muscle_development | 0.90798252 |
| 99 | MP0004085_abnormal_heartbeat | 0.90309745 |
| 100 | MP0005508_abnormal_skeleton_morphology | 0.89675614 |
| 101 | MP0002736_abnormal_nociception_after | 0.89657861 |
| 102 | MP0005595_abnormal_vascular_smooth | 0.89588537 |
| 103 | MP0001346_abnormal_lacrimal_gland | 0.87736296 |
| 104 | MP0009333_abnormal_splenocyte_physiolog | 0.86697697 |
| 105 | MP0004272_abnormal_basement_membrane | 0.86623708 |
| 106 | MP0001963_abnormal_hearing_physiology | 0.86466803 |
| 107 | MP0000470_abnormal_stomach_morphology | 0.86353848 |
| 108 | MP0002896_abnormal_bone_mineralization | 0.83949361 |
| 109 | MP0005171_absent_coat_pigmentation | 0.82929492 |
| 110 | MP0000249_abnormal_blood_vessel | 0.82854479 |
| 111 | MP0000858_altered_metastatic_potential | 0.81484081 |
| 112 | MP0002405_respiratory_system_inflammati | 0.81311039 |
| 113 | MP0002163_abnormal_gland_morphology | 0.80701040 |
| 114 | MP0002723_abnormal_immune_serum | 0.80378846 |
| 115 | MP0002108_abnormal_muscle_morphology | 0.80363926 |
| 116 | MP0002063_abnormal_learning/memory/cond | 0.79099816 |
| 117 | MP0001835_abnormal_antigen_presentation | 0.78837677 |
| 118 | MP0002067_abnormal_sensory_capabilities | 0.78551648 |
| 119 | MP0005310_abnormal_salivary_gland | 0.78078909 |
| 120 | MP0001970_abnormal_pain_threshold | 0.77135103 |
| 121 | MP0004084_abnormal_cardiac_muscle | 0.75602338 |
| 122 | MP0010368_abnormal_lymphatic_system | 0.75090560 |
| 123 | MP0003795_abnormal_bone_structure | 0.74852112 |
| 124 | MP0000759_abnormal_skeletal_muscle | 0.74585767 |
| 125 | MP0005464_abnormal_platelet_physiology | 0.74337589 |
| 126 | MP0001819_abnormal_immune_cell | 0.73551249 |
| 127 | MP0002420_abnormal_adaptive_immunity | 0.73477711 |
| 128 | MP0003075_altered_response_to | 0.72878211 |
| 129 | MP0004885_abnormal_endolymph | 0.72434712 |
| 130 | MP0005647_abnormal_sex_gland | 0.72431277 |
| 131 | MP0002452_abnormal_antigen_presenting | 0.72095814 |
| 132 | MP0003868_abnormal_feces_composition | 0.70956630 |
| 133 | MP0002970_abnormal_white_adipose | 0.70603611 |
| 134 | MP0001324_abnormal_eye_pigmentation | 0.70294228 |
| 135 | MP0002098_abnormal_vibrissa_morphology | 0.69580518 |
| 136 | MP0001663_abnormal_digestive_system | 0.68067734 |
| 137 | MP0004233_abnormal_muscle_weight | 0.67901099 |
| 138 | MP0009931_abnormal_skin_appearance | 0.67622179 |
| 139 | MP0001502_abnormal_circadian_rhythm | 0.67573470 |
| 140 | MP0009115_abnormal_fat_cell | 0.66779830 |
| 141 | MP0005167_abnormal_blood-brain_barrier | 0.66117954 |
| 142 | MP0001243_abnormal_dermal_layer | 0.65900210 |
| 143 | MP0002998_abnormal_bone_remodeling | 0.65830100 |
| 144 | MP0008569_lethality_at_weaning | 0.65459909 |
| 145 | MP0001542_abnormal_bone_strength | 0.65195381 |
| 146 | MP0004134_abnormal_chest_morphology | 0.64419865 |
| 147 | MP0002796_impaired_skin_barrier | 0.64396979 |
| 148 | MP0004510_myositis | 0.63950451 |
| 149 | MP0010386_abnormal_urinary_bladder | 0.63057324 |
| 150 | MP0002734_abnormal_mechanical_nocicepti | 0.62115416 |
| 151 | MP0000026_abnormal_inner_ear | 0.61927822 |
| 152 | MP0008775_abnormal_heart_ventricle | 0.60391163 |
| 153 | MP0002638_abnormal_pupillary_reflex | 0.59435483 |
| 154 | MP0001293_anophthalmia | 0.58138350 |
| 155 | MP0002396_abnormal_hematopoietic_system | 0.56098957 |
| 156 | MP0004036_abnormal_muscle_relaxation | 0.55537743 |
| 157 | MP0009780_abnormal_chondrocyte_physiolo | 0.54843835 |
| 158 | MP0006138_congestive_heart_failure | 0.54455616 |
| 159 | MP0005257_abnormal_intraocular_pressure | 0.54288674 |
| 160 | MP0004484_altered_response_of | 0.53606874 |
| 161 | MP0003566_abnormal_cell_adhesion | 0.53266782 |
| 162 | MP0003938_abnormal_ear_development | 0.52927604 |
| 163 | MP0002127_abnormal_cardiovascular_syste | 0.52836853 |
| 164 | MP0003385_abnormal_body_wall | 0.50134258 |
| 165 | MP0004043_abnormal_pH_regulation | 0.48835751 |
| 166 | MP0005503_abnormal_tendon_morphology | 0.46696438 |
| 167 | MP0000516_abnormal_urinary_system | 0.46262637 |
| 168 | MP0005367_renal/urinary_system_phenotyp | 0.46262637 |
| 169 | MP0002102_abnormal_ear_morphology | 0.45976304 |
| 170 | MP0005387_immune_system_phenotype | 0.45599311 |
| 171 | MP0001790_abnormal_immune_system | 0.45599311 |
| 172 | MP0002075_abnormal_coat/hair_pigmentati | 0.44240697 |
| 173 | MP0001765_abnormal_ion_homeostasis | 0.41910128 |
| 174 | MP0001529_abnormal_vocalization | 0.41898360 |
| 175 | MP0002066_abnormal_motor_capabilities/c | 0.41800624 |
| 176 | MP0002069_abnormal_eating/drinking_beha | 0.41201568 |
| 177 | MP0002733_abnormal_thermal_nociception | 0.41041273 |
| 178 | MP0004782_abnormal_surfactant_physiolog | 0.41035096 |
| 179 | MP0004811_abnormal_neuron_physiology | 0.40622565 |
| 180 | MP0000639_abnormal_adrenal_gland | 0.37136037 |
| 181 | MP0003936_abnormal_reproductive_system | 0.36392504 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Unilateral renal agenesis (HP:0000122) | 8.87455850 |
| 2 | Alopecia of scalp (HP:0002293) | 8.80918440 |
| 3 | Follicular hyperkeratosis (HP:0007502) | 7.64913088 |
| 4 | Bilateral sensorineural hearing impairment (HP:0008619) | 7.44929431 |
| 5 | Abnormality of dental color (HP:0011073) | 6.94254952 |
| 6 | Absent eyebrow (HP:0002223) | 6.47326443 |
| 7 | Absent/shortened dynein arms (HP:0200106) | 6.30433886 |
| 8 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 6.30433886 |
| 9 | Absent eyelashes (HP:0000561) | 6.09559600 |
| 10 | Cheilitis (HP:0100825) | 5.83588722 |
| 11 | Chronic otitis media (HP:0000389) | 5.53818107 |
| 12 | Recurrent corneal erosions (HP:0000495) | 5.41832444 |
| 13 | Hyperphosphatemia (HP:0002905) | 4.64567157 |
| 14 | Abolished electroretinogram (ERG) (HP:0000550) | 4.20691589 |
| 15 | Obstructive sleep apnea (HP:0002870) | 4.10613731 |
| 16 | Protrusio acetabuli (HP:0003179) | 3.83158300 |
| 17 | Ectropion (HP:0000656) | 3.79191895 |
| 18 | Erythroderma (HP:0001019) | 3.78899875 |
| 19 | Abnormal ciliary motility (HP:0012262) | 3.71705198 |
| 20 | Renal dysplasia (HP:0000110) | 3.70890868 |
| 21 | Cervical subluxation (HP:0003308) | 3.70372625 |
| 22 | Tetany (HP:0001281) | 3.60383753 |
| 23 | Abnormal respiratory motile cilium morphology (HP:0005938) | 3.54360628 |
| 24 | Abnormal respiratory epithelium morphology (HP:0012253) | 3.54360628 |
| 25 | Cerebral aneurysm (HP:0004944) | 3.46935009 |
| 26 | Broad face (HP:0000283) | 3.35584048 |
| 27 | Absent hair (HP:0002298) | 3.24562603 |
| 28 | Premature rupture of membranes (HP:0001788) | 3.24513858 |
| 29 | Thin bony cortex (HP:0002753) | 3.13911994 |
| 30 | Chronic sinusitis (HP:0011109) | 3.10904855 |
| 31 | Blepharitis (HP:0000498) | 3.00879302 |
| 32 | Dysostosis multiplex (HP:0000943) | 2.92566424 |
| 33 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.88510855 |
| 34 | Mucopolysacchariduria (HP:0008155) | 2.88510855 |
| 35 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.86866441 |
| 36 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.86866441 |
| 37 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.86866441 |
| 38 | Abnormal respiratory motile cilium physiology (HP:0012261) | 2.81140653 |
| 39 | Stridor (HP:0010307) | 2.79710269 |
| 40 | Palmoplantar hyperkeratosis (HP:0000972) | 2.77102228 |
| 41 | Keratitis (HP:0000491) | 2.74956389 |
| 42 | J-shaped sella turcica (HP:0002680) | 2.73667522 |
| 43 | Neoplasm of the lung (HP:0100526) | 2.69982039 |
| 44 | Atrophic scars (HP:0001075) | 2.69657092 |
| 45 | Joint stiffness (HP:0001387) | 2.69485957 |
| 46 | Rhinitis (HP:0012384) | 2.66350145 |
| 47 | Palmar hyperkeratosis (HP:0010765) | 2.62545184 |
| 48 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 2.62478495 |
| 49 | Fragile skin (HP:0001030) | 2.60188517 |
| 50 | Mitral stenosis (HP:0001718) | 2.59376133 |
| 51 | Vertebral arch anomaly (HP:0008438) | 2.57548765 |
| 52 | Aortic aneurysm (HP:0004942) | 2.51797416 |
| 53 | Shallow orbits (HP:0000586) | 2.49989151 |
| 54 | Increased connective tissue (HP:0009025) | 2.46781601 |
| 55 | Emphysema (HP:0002097) | 2.45070596 |
| 56 | Increased IgE level (HP:0003212) | 2.45059482 |
| 57 | Aneurysm (HP:0002617) | 2.45045664 |
| 58 | Mitral regurgitation (HP:0001653) | 2.44702469 |
| 59 | Broad metatarsal (HP:0001783) | 2.43516324 |
| 60 | Increased variability in muscle fiber diameter (HP:0003557) | 2.41863998 |
| 61 | Chronic hepatic failure (HP:0100626) | 2.36555461 |
| 62 | Lymphangioma (HP:0100764) | 2.36462692 |
| 63 | Vertigo (HP:0002321) | 2.35365457 |
| 64 | Aortic regurgitation (HP:0001659) | 2.34975124 |
| 65 | Biconcave vertebral bodies (HP:0004586) | 2.33772870 |
| 66 | Asymmetric septal hypertrophy (HP:0001670) | 2.31558855 |
| 67 | Erythema (HP:0010783) | 2.31231092 |
| 68 | Plagiocephaly (HP:0001357) | 2.30176174 |
| 69 | Bladder diverticulum (HP:0000015) | 2.30111067 |
| 70 | Small epiphyses (HP:0010585) | 2.29707902 |
| 71 | Focal motor seizures (HP:0011153) | 2.29145451 |
| 72 | Neoplasm of the respiratory system (HP:0100606) | 2.27101576 |
| 73 | Eczematoid dermatitis (HP:0000976) | 2.26653242 |
| 74 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.25178509 |
| 75 | Corneal erosion (HP:0200020) | 2.24396911 |
| 76 | Distal upper limb amyotrophy (HP:0007149) | 2.23535822 |
| 77 | Upper limb amyotrophy (HP:0009129) | 2.23535822 |
| 78 | Hemorrhage of the eye (HP:0011885) | 2.23333626 |
| 79 | Disproportionate tall stature (HP:0001519) | 2.21323790 |
| 80 | Abnormal biliary tract physiology (HP:0012439) | 2.20752401 |
| 81 | Bile duct proliferation (HP:0001408) | 2.20752401 |
| 82 | Type 1 muscle fiber predominance (HP:0003803) | 2.17631505 |
| 83 | Dilatation of the ascending aorta (HP:0005111) | 2.16094949 |
| 84 | Hyperactive renin-angiotensin system (HP:0000841) | 2.15720141 |
| 85 | Malnutrition (HP:0004395) | 2.14293871 |
| 86 | Congenital sensorineural hearing impairment (HP:0008527) | 2.09994089 |
| 87 | Distal lower limb amyotrophy (HP:0008944) | 2.09675816 |
| 88 | Abnormality of the nasal mucosa (HP:0000433) | 2.09425666 |
| 89 | Hypoplasia of the capital femoral epiphysis (HP:0003090) | 2.08734785 |
| 90 | Aortic dissection (HP:0002647) | 2.08369363 |
| 91 | Systemic lupus erythematosus (HP:0002725) | 2.07921857 |
| 92 | Abnormality of incisor morphology (HP:0011063) | 2.06276676 |
| 93 | Nuclear cataract (HP:0100018) | 2.05862874 |
| 94 | Metabolic alkalosis (HP:0200114) | 2.05565206 |
| 95 | Blue sclerae (HP:0000592) | 2.05389771 |
| 96 | Hyperacusis (HP:0010780) | 2.04584433 |
| 97 | Spinal rigidity (HP:0003306) | 2.03577448 |
| 98 | Urticaria (HP:0001025) | 2.03279037 |
| 99 | Plantar hyperkeratosis (HP:0007556) | 2.03017142 |
| 100 | Spinal canal stenosis (HP:0003416) | 2.02750594 |
| 101 | Atelectasis (HP:0100750) | 2.01528139 |
| 102 | Atrial fibrillation (HP:0005110) | 2.01340768 |
| 103 | Parakeratosis (HP:0001036) | 10.2351722 |
| 104 | Renal agenesis (HP:0000104) | 1.99975740 |
| 105 | Distal lower limb muscle weakness (HP:0009053) | 1.99857000 |
| 106 | Vertebral compression fractures (HP:0002953) | 1.99826946 |
| 107 | Peritonitis (HP:0002586) | 1.98533265 |
| 108 | Supranuclear gaze palsy (HP:0000605) | 1.98150693 |
| 109 | Amelogenesis imperfecta (HP:0000705) | 1.98100817 |
| 110 | Easy fatigability (HP:0003388) | 1.96646671 |
| 111 | Abnormality of the renal collecting system (HP:0004742) | 1.94774967 |
| 112 | Rectal prolapse (HP:0002035) | 1.92926727 |
| 113 | Septo-optic dysplasia (HP:0100842) | 1.92177519 |
| 114 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.90421774 |
| 115 | Flat acetabular roof (HP:0003180) | 1.89692371 |
| 116 | Abnormality of the right ventricle (HP:0001707) | 1.87802753 |
| 117 | Osteomalacia (HP:0002749) | 1.86482271 |
| 118 | Primary atrial arrhythmia (HP:0001692) | 1.86299756 |
| 119 | Corneal dystrophy (HP:0001131) | 1.85366654 |
| 120 | White forelock (HP:0002211) | 1.83925667 |
| 121 | Genu recurvatum (HP:0002816) | 1.83754569 |
| 122 | Joint laxity (HP:0001388) | 1.83743262 |
| 123 | Vascular tortuosity (HP:0004948) | 1.83110683 |
| 124 | Hypohidrosis (HP:0000966) | 1.82948042 |
| 125 | Patchy hypopigmentation of hair (HP:0011365) | 1.82303114 |
| 126 | Exercise-induced myalgia (HP:0003738) | 1.81870487 |
| 127 | Febrile seizures (HP:0002373) | 1.81387862 |
| 128 | Ulnar deviation of the wrist (HP:0003049) | 1.80652190 |
| 129 | Ectopic kidney (HP:0000086) | 1.80055294 |
| 130 | Neurofibrillary tangles (HP:0002185) | 1.79878029 |
| 131 | Hyperaldosteronism (HP:0000859) | 1.78659193 |
| 132 | Premature skin wrinkling (HP:0100678) | 1.78407252 |
| 133 | Arthropathy (HP:0003040) | 1.77649657 |
| 134 | Annular pancreas (HP:0001734) | 1.77641994 |
| 135 | Hypoventilation (HP:0002791) | 1.75544877 |
| 136 | Slender build (HP:0001533) | 1.75480060 |
| 137 | Duplicated collecting system (HP:0000081) | 1.75275070 |
| 138 | Turricephaly (HP:0000262) | 1.75243032 |
| 139 | Mitral valve prolapse (HP:0001634) | 1.74796369 |
| 140 | Supraventricular tachycardia (HP:0004755) | 1.73338779 |
| 141 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.72892642 |
| 142 | Deformed sella turcica (HP:0002681) | 1.72813971 |
| 143 | Ulnar claw (HP:0001178) | 1.72637459 |
| 144 | Sparse eyelashes (HP:0000653) | 1.71766836 |
| 145 | Myositis (HP:0100614) | 1.71631391 |
| 146 | Spondylolisthesis (HP:0003302) | 1.70596260 |
| 147 | Pustule (HP:0200039) | 1.69795204 |
| 148 | Wormian bones (HP:0002645) | 1.68804609 |
| 149 | Myopathic facies (HP:0002058) | 1.68192177 |
| 150 | Melanoma (HP:0002861) | 1.67970544 |
| 151 | Difficulty climbing stairs (HP:0003551) | 1.66385221 |
| 152 | Supraventricular arrhythmia (HP:0005115) | 1.66372118 |
| 153 | Nasal polyposis (HP:0100582) | 1.66333844 |
| 154 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.65898747 |
| 155 | Oligodontia (HP:0000677) | 1.65793599 |
| 156 | Hypercortisolism (HP:0001578) | 1.65649399 |
| 157 | Arterial tortuosity (HP:0005116) | 1.65474815 |
| 158 | Abnormality of the thoracic spine (HP:0100711) | 1.65260459 |
| 159 | Colitis (HP:0002583) | 1.65231452 |
| 160 | Loss of speech (HP:0002371) | 1.65111300 |
| 161 | Abnormality of renin-angiotensin system (HP:0000847) | 1.64566646 |
| 162 | Round ear (HP:0100830) | 1.64234432 |
| 163 | Conical tooth (HP:0000698) | 1.64000039 |
| 164 | Interstitial pulmonary disease (HP:0006530) | 1.63878518 |
| 165 | Hypocalcemia (HP:0002901) | 1.63726907 |
| 166 | Cellulitis (HP:0100658) | 1.63638362 |
| 167 | Polygenic inheritance (HP:0010982) | 1.62908942 |
| 168 | Absent epiphyses (HP:0010577) | 1.62611024 |
| 169 | Aplasia/Hypoplasia of the capital femoral epiphysis (HP:0005003) | 1.62611024 |
| 170 | Spontaneous hematomas (HP:0007420) | 1.61794930 |
| 171 | Gingivitis (HP:0000230) | 1.61501628 |
| 172 | Abnormality of the fingertips (HP:0001211) | 1.59838716 |
| 173 | Bronchomalacia (HP:0002780) | 1.59475221 |
| 174 | Fetal akinesia sequence (HP:0001989) | 1.58174743 |
| 175 | Papilledema (HP:0001085) | 1.58065347 |
| 176 | Axonal loss (HP:0003447) | 1.57045866 |
| 177 | Long palpebral fissure (HP:0000637) | 1.57005090 |
| 178 | Ulnar bowing (HP:0003031) | 1.56952008 |
| 179 | Widely spaced teeth (HP:0000687) | 1.56743734 |
| 180 | Aortic valve stenosis (HP:0001650) | 1.56734268 |
| 181 | Syncope (HP:0001279) | 1.55990094 |
| 182 | Hypoparathyroidism (HP:0000829) | 1.55802178 |
| 183 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.55286702 |
| 184 | Abnormality of chloride homeostasis (HP:0011422) | 1.54992943 |
| 185 | Supernumerary nipples (HP:0002558) | 1.53679148 |
| 186 | Microdontia (HP:0000691) | 1.52906222 |
| 187 | Lymphopenia (HP:0001888) | 1.51950955 |
| 188 | Aplasia cutis congenita (HP:0001057) | 1.50634304 |
| 189 | Coronal craniosynostosis (HP:0004440) | 1.50618855 |
| 190 | Malignant hyperthermia (HP:0002047) | 1.50600419 |
| 191 | Hypergonadotropic hypogonadism (HP:0000815) | 1.49453172 |
| 192 | Convex nasal ridge (HP:0000444) | 1.44138619 |
| 193 | Oligohydramnios (HP:0001562) | 1.41702741 |
| 194 | Limited hip movement (HP:0008800) | 1.40439324 |
| 195 | Cutaneous finger syndactyly (HP:0010554) | 1.39763268 |
| 196 | Midline defect of the nose (HP:0004122) | 1.39534092 |
| 197 | Atrioventricular block (HP:0001678) | 1.39166974 |
| 198 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.37921704 |
| 199 | Prostate neoplasm (HP:0100787) | 1.36230680 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | SIK3 | 9.77237008 |
| 2 | SIK2 | 7.02951280 |
| 3 | SIK1 | 6.12541884 |
| 4 | TRIB3 | 4.13548172 |
| 5 | MARK3 | 3.33472253 |
| 6 | ERN1 | 3.24372485 |
| 7 | RIPK1 | 2.70947331 |
| 8 | EPHA2 | 2.59574931 |
| 9 | LATS1 | 2.06646002 |
| 10 | EPHB1 | 1.92802284 |
| 11 | PAK4 | 1.87946617 |
| 12 | CDC42BPA | 1.87773059 |
| 13 | EPHA4 | 1.86635675 |
| 14 | PRKD2 | 1.84781134 |
| 15 | FGFR4 | 1.82525446 |
| 16 | MAP2K3 | 1.72990507 |
| 17 | MARK2 | 1.70670860 |
| 18 | CDK8 | 1.68583562 |
| 19 | ICK | 1.63554862 |
| 20 | MAP3K12 | 1.62994086 |
| 21 | TNIK | 1.56951497 |
| 22 | MAP3K6 | 1.55690145 |
| 23 | MAP3K10 | 1.51957432 |
| 24 | NTRK3 | 1.51129452 |
| 25 | PKN2 | 1.49366370 |
| 26 | STK38 | 1.49264317 |
| 27 | PDGFRA | 1.48766328 |
| 28 | SMG1 | 1.46792766 |
| 29 | TYK2 | 1.39402086 |
| 30 | ZAP70 | 1.37871821 |
| 31 | TXK | 1.36940920 |
| 32 | STK38L | 1.36696193 |
| 33 | PRPF4B | 1.35032052 |
| 34 | DDR2 | 1.34193221 |
| 35 | WNK1 | 1.30101862 |
| 36 | RIPK4 | 1.23506750 |
| 37 | ADRBK2 | 1.23429628 |
| 38 | EEF2K | 1.21103806 |
| 39 | MAP3K13 | 1.18508171 |
| 40 | CAMK1 | 1.17744432 |
| 41 | MAP2K6 | 1.15317888 |
| 42 | MAPK15 | 1.15171451 |
| 43 | HIPK2 | 1.13865675 |
| 44 | TBK1 | 1.12945087 |
| 45 | RPS6KA2 | 1.11790343 |
| 46 | TYRO3 | 1.10282124 |
| 47 | MAP3K3 | 1.08903058 |
| 48 | LATS2 | 1.07071795 |
| 49 | MAPK13 | 0.99742302 |
| 50 | PTK6 | 0.98389816 |
| 51 | CAMKK1 | 0.96665473 |
| 52 | PDPK1 | 0.93911363 |
| 53 | NTRK1 | 0.92710199 |
| 54 | GRK6 | 0.89858754 |
| 55 | SGK2 | 0.88925833 |
| 56 | MST1R | 0.86291124 |
| 57 | IRAK3 | 0.86270947 |
| 58 | MTOR | 0.83846388 |
| 59 | FGFR3 | 0.83584411 |
| 60 | PTK2 | 0.83475555 |
| 61 | INSRR | 0.81455956 |
| 62 | CAMK4 | 0.81348293 |
| 63 | TNK2 | 0.80634424 |
| 64 | BTK | 0.80491791 |
| 65 | MAP3K1 | 0.80220071 |
| 66 | DYRK1B | 0.79902120 |
| 67 | TAOK1 | 0.78854450 |
| 68 | PDGFRB | 0.76454657 |
| 69 | BMX | 0.75307746 |
| 70 | KIT | 0.74630538 |
| 71 | CDK12 | 0.73958080 |
| 72 | MAP2K4 | 0.72956906 |
| 73 | EPHA3 | 0.72267903 |
| 74 | PDK1 | 0.71515559 |
| 75 | CSK | 0.70516905 |
| 76 | MAP2K7 | 0.69821106 |
| 77 | MAP2K2 | 0.67974293 |
| 78 | RET | 0.66651913 |
| 79 | TESK1 | 0.64137887 |
| 80 | PRKD1 | 0.63285196 |
| 81 | SGK3 | 0.62290091 |
| 82 | CSNK1D | 0.61404291 |
| 83 | MAPKAPK3 | 0.61210148 |
| 84 | TAOK2 | 0.59293259 |
| 85 | MAP3K7 | 0.57883760 |
| 86 | BRD4 | 0.57282457 |
| 87 | MAP3K14 | 0.54997884 |
| 88 | PRKAA2 | 0.54407268 |
| 89 | CASK | 0.53336811 |
| 90 | NTRK2 | 0.52632253 |
| 91 | CHUK | 0.52419332 |
| 92 | CAMK1G | 0.50250670 |
| 93 | IKBKE | 0.50073153 |
| 94 | KSR2 | 0.49836929 |
| 95 | SGK494 | 0.48888405 |
| 96 | SGK223 | 0.48888405 |
| 97 | LMTK2 | 0.48384683 |
| 98 | MET | 0.48065725 |
| 99 | SGK1 | 0.48021383 |
| 100 | IKBKB | 0.47795147 |
| 101 | PRKAA1 | 0.47730976 |
| 102 | GRK7 | 0.46678110 |
| 103 | PTK2B | 0.45312270 |
| 104 | MAPK4 | 0.44591080 |
| 105 | UHMK1 | 0.43289018 |
| 106 | CSNK1A1L | 0.42894694 |
| 107 | MYLK | 0.42290762 |
| 108 | LCK | 0.42281266 |
| 109 | PRKD3 | 0.41860502 |
| 110 | PRKG1 | 0.38428506 |
| 111 | MAP4K1 | 0.37920184 |
| 112 | PRKG2 | 0.37836010 |
| 113 | JAK2 | 0.37174543 |
| 114 | ALK | 0.36974883 |
| 115 | FES | 0.35796996 |
| 116 | MAP3K4 | 0.35793658 |
| 117 | DMPK | 0.35373201 |
| 118 | CAMK1D | 0.32810747 |
| 119 | MAPK12 | 0.31940669 |
| 120 | ZAK | 0.31377729 |
| 121 | PKN1 | 0.31199738 |
| 122 | HCK | 0.30414098 |
| 123 | MAPK11 | 0.27743754 |
| 124 | BLK | 0.27452817 |
| 125 | SRPK1 | 0.27295507 |
| 126 | TEC | 0.27140018 |
| 127 | TGFBR2 | 0.26432859 |
| 128 | DAPK2 | 0.25272329 |
| 129 | PRKCQ | 0.24634877 |
| 130 | RPS6KC1 | 0.24485444 |
| 131 | RPS6KL1 | 0.24485444 |
| 132 | BMPR2 | 0.24105117 |
| 133 | FGR | 0.23171547 |
| 134 | PHKG2 | 0.22926945 |
| 135 | PHKG1 | 0.22926945 |
| 136 | YES1 | 0.22108565 |
| 137 | SYK | 0.21988432 |
| 138 | MAP3K11 | 0.21391328 |
| 139 | STK3 | 0.21240465 |
| 140 | CAMK2A | 0.20437754 |
| 141 | LYN | 0.19359802 |
| 142 | CDK7 | 0.18806206 |
| 143 | IRAK4 | 0.18715352 |
| 144 | FYN | 0.18384503 |
| 145 | BMPR1B | 0.18165152 |
| 146 | CDK3 | 0.17822663 |
| 147 | IRAK2 | 0.17675753 |
| 148 | ITK | 0.17447386 |
| 149 | MAPK7 | 0.16785110 |
| 150 | RPS6KA6 | 0.16499764 |
| 151 | MUSK | 0.15304918 |
| 152 | SRC | 0.14975414 |
| 153 | STK11 | 0.14888428 |
| 154 | CDK5 | 0.14410477 |
| 155 | MAP3K5 | 0.14149166 |
| 156 | AKT1 | 0.14054047 |
| 157 | PRKCH | 0.13805248 |
| 158 | JAK1 | 0.13715657 |
| 159 | PIK3CA | 0.13631214 |
| 160 | PRKCE | 0.13203352 |
| 161 | JAK3 | 0.12507658 |
| 162 | TTN | 0.12491167 |
| 163 | OBSCN | 0.11809586 |
| 164 | EPHB2 | 0.11565642 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 3.50694716 |
| 2 | Other glycan degradation_Homo sapiens_hsa00511 | 2.95513301 |
| 3 | Mineral absorption_Homo sapiens_hsa04978 | 2.50990246 |
| 4 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.23167082 |
| 5 | Morphine addiction_Homo sapiens_hsa05032 | 2.22237086 |
| 6 | Calcium signaling pathway_Homo sapiens_hsa04020 | 2.21892544 |
| 7 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.08058740 |
| 8 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 2.03767695 |
| 9 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.83595094 |
| 10 | Taste transduction_Homo sapiens_hsa04742 | 1.83429023 |
| 11 | Circadian entrainment_Homo sapiens_hsa04713 | 1.83092082 |
| 12 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.79187576 |
| 13 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.76463762 |
| 14 | GABAergic synapse_Homo sapiens_hsa04727 | 1.75433613 |
| 15 | Axon guidance_Homo sapiens_hsa04360 | 1.74672900 |
| 16 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.68048529 |
| 17 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.67201394 |
| 18 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.61558101 |
| 19 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.57928952 |
| 20 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.54406868 |
| 21 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.52123209 |
| 22 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.43396321 |
| 23 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.41720063 |
| 24 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.38539892 |
| 25 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.31317262 |
| 26 | Salivary secretion_Homo sapiens_hsa04970 | 1.30389004 |
| 27 | Insulin secretion_Homo sapiens_hsa04911 | 1.29930978 |
| 28 | Renin secretion_Homo sapiens_hsa04924 | 1.28962264 |
| 29 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.28007779 |
| 30 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.26437893 |
| 31 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.25550417 |
| 32 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.24686111 |
| 33 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.24569707 |
| 34 | Lysine degradation_Homo sapiens_hsa00310 | 1.22762827 |
| 35 | Olfactory transduction_Homo sapiens_hsa04740 | 1.22700586 |
| 36 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.22169483 |
| 37 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.20545570 |
| 38 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.19712123 |
| 39 | Melanoma_Homo sapiens_hsa05218 | 1.17938011 |
| 40 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.17845030 |
| 41 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.16264626 |
| 42 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.15542056 |
| 43 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 1.13211287 |
| 44 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.12831681 |
| 45 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.11587434 |
| 46 | Circadian rhythm_Homo sapiens_hsa04710 | 1.11015113 |
| 47 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.10343568 |
| 48 | Long-term potentiation_Homo sapiens_hsa04720 | 1.10303881 |
| 49 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.10088154 |
| 50 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.09956614 |
| 51 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.09904863 |
| 52 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 1.09900357 |
| 53 | Focal adhesion_Homo sapiens_hsa04510 | 1.09664154 |
| 54 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.09612178 |
| 55 | Lysosome_Homo sapiens_hsa04142 | 1.07928599 |
| 56 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.07741288 |
| 57 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.06877758 |
| 58 | Amoebiasis_Homo sapiens_hsa05146 | 1.05058349 |
| 59 | Ras signaling pathway_Homo sapiens_hsa04014 | 1.04363261 |
| 60 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.01901980 |
| 61 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.01718815 |
| 62 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.00997588 |
| 63 | Long-term depression_Homo sapiens_hsa04730 | 1.00817268 |
| 64 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.00090963 |
| 65 | Insulin resistance_Homo sapiens_hsa04931 | 0.99920428 |
| 66 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.99557835 |
| 67 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.97279642 |
| 68 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.97030566 |
| 69 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.96450943 |
| 70 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.96316429 |
| 71 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.95752008 |
| 72 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.94038026 |
| 73 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.92525027 |
| 74 | Cocaine addiction_Homo sapiens_hsa05030 | 0.91753260 |
| 75 | Tuberculosis_Homo sapiens_hsa05152 | 0.91137236 |
| 76 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.89893040 |
| 77 | Hepatitis C_Homo sapiens_hsa05160 | 0.89803236 |
| 78 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.89416404 |
| 79 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.88953442 |
| 80 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.87699368 |
| 81 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.87435048 |
| 82 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.86414653 |
| 83 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.85883916 |
| 84 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.85116263 |
| 85 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.84294074 |
| 86 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.84197220 |
| 87 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.84190523 |
| 88 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.83727942 |
| 89 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.82928978 |
| 90 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.82784966 |
| 91 | Prion diseases_Homo sapiens_hsa05020 | 0.82417099 |
| 92 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.81923420 |
| 93 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.81216273 |
| 94 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.79597627 |
| 95 | Pertussis_Homo sapiens_hsa05133 | 0.79368225 |
| 96 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.79178229 |
| 97 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.78655594 |
| 98 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.78632892 |
| 99 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.78114945 |
| 100 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.78112085 |
| 101 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.76459514 |
| 102 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.75930982 |
| 103 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.75838683 |
| 104 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.75586851 |
| 105 | Malaria_Homo sapiens_hsa05144 | 0.74992448 |
| 106 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.74938183 |
| 107 | Influenza A_Homo sapiens_hsa05164 | 0.74602536 |
| 108 | ABC transporters_Homo sapiens_hsa02010 | 0.73691355 |
| 109 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.73421385 |
| 110 | Allograft rejection_Homo sapiens_hsa05330 | 0.73074399 |
| 111 | Endocytosis_Homo sapiens_hsa04144 | 0.72513870 |
| 112 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.70815316 |
| 113 | Bladder cancer_Homo sapiens_hsa05219 | 0.70611432 |
| 114 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.69445586 |
| 115 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.68806566 |
| 116 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.68413871 |
| 117 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.67828664 |
| 118 | Measles_Homo sapiens_hsa05162 | 0.67525294 |
| 119 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.66206037 |
| 120 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.66184557 |
| 121 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.65936894 |
| 122 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.65252503 |
| 123 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.65217526 |
| 124 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.63983198 |
| 125 | Leishmaniasis_Homo sapiens_hsa05140 | 0.63896598 |
| 126 | Hepatitis B_Homo sapiens_hsa05161 | 0.62782981 |
| 127 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.61801190 |
| 128 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.61635454 |
| 129 | Melanogenesis_Homo sapiens_hsa04916 | 0.60889460 |
| 130 | Endometrial cancer_Homo sapiens_hsa05213 | 0.59116053 |
| 131 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.58332131 |
| 132 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.57886535 |
| 133 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.56454419 |
| 134 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.55942842 |
| 135 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.55608542 |
| 136 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.55383169 |
| 137 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.53093744 |
| 138 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.52870658 |
| 139 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.52164906 |
| 140 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.51555243 |
| 141 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.51130569 |
| 142 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.49294524 |
| 143 | Glioma_Homo sapiens_hsa05214 | 0.48730341 |
| 144 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.47645009 |
| 145 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.46844696 |
| 146 | Platelet activation_Homo sapiens_hsa04611 | 0.46043908 |
| 147 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.45685390 |
| 148 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.45441825 |
| 149 | Salmonella infection_Homo sapiens_hsa05132 | 0.45244337 |
| 150 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.44601370 |
| 151 | HTLV-I infection_Homo sapiens_hsa05166 | 0.43801992 |
| 152 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.43687624 |
| 153 | Adherens junction_Homo sapiens_hsa04520 | 0.43243814 |
| 154 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.43121119 |
| 155 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.42808853 |
| 156 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.42412812 |
| 157 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.41440333 |

